Artivion Inc (AORT)

NYSE

$25.38

Artivion Inc. manufactures, processes and distributes implantable human tissues and medical devices worldwide.

Sector:

Industry:

68 analysts

Strong Buy

Target: $42 (+65.52%)

Market Cap

$1.17B

FCF 5Y CAGR

+104.87%

P/E Ratio

130.94

Free Cash Flow Yield

1.25%

Adjust inflation

Log

Valuation

Market Cap$1.17B

P/E130.94

Forward P/E156.25

PEG181.50

P/S2.69

P/B2.49

Profitability

Total Revenue (TTM)$459M

Gross Profit (TTM)$296M

EBITDA$61M

Profit Margin1.2%

Operating Margin5%

EPS$0.19

Financial Health

Debt-to-Equity47.8%

Free Cash Flow Yield1.25%

Growth & Risk

EPS 5Y CAGR+11.56%

Revenue 5Y CAGR+12.21%

FCF 5Y CAGR+104.87%

Beta (5Y)0.66

Sharpe Ratio-0.16